These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis. Gannon G; Mandriota SJ; Cui L; Baetens D; Pepper MS; Christofori G Cancer Res; 2002 Jan; 62(2):603-8. PubMed ID: 11809716 [TBL] [Abstract][Full Text] [Related]
5. Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner. Dace DS; Chen PW; Alizadeh H; Niederkorn JY J Leukoc Biol; 2007 Feb; 81(2):421-9. PubMed ID: 17077163 [TBL] [Abstract][Full Text] [Related]
6. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432 [TBL] [Abstract][Full Text] [Related]
7. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103 [TBL] [Abstract][Full Text] [Related]
8. IFN-gamma expression in CD8+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4+ T cell death. Atsumi T; Sato M; Kamimura D; Moroi A; Iwakura Y; Betz UA; Yoshimura A; Nishihara M; Hirano T; Murakami M Int Immunol; 2009 Jan; 21(1):73-80. PubMed ID: 19050105 [TBL] [Abstract][Full Text] [Related]
9. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice. Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908 [TBL] [Abstract][Full Text] [Related]
11. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses. Zhu BQ; Ju SW; Shu YQ Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623 [TBL] [Abstract][Full Text] [Related]
12. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Christofori G; Naik P; Hanahan D Nature; 1994 Jun; 369(6479):414-8. PubMed ID: 7910953 [TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. Ganss R; Hanahan D Cancer Res; 1998 Oct; 58(20):4673-81. PubMed ID: 9788621 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control. Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230 [TBL] [Abstract][Full Text] [Related]
15. IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host. Liu XS; Leerberg J; MacDonald K; Leggatt GR; Frazer IH J Immunol; 2009 Jul; 183(1):51-8. PubMed ID: 19535638 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer. Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells. Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332 [TBL] [Abstract][Full Text] [Related]
18. Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease. Sun Y; Wu XX; Yin Y; Gong FY; Shen Y; Cai TT; Zhou XB; Wu XF; Xu Q Biochem Pharmacol; 2010 Jan; 79(2):229-38. PubMed ID: 19698701 [TBL] [Abstract][Full Text] [Related]
19. Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis. Dayer Schneider J; Seibold I; Saxer-Sekulic N; Paredes BE; Saurer L; Mueller C Eur J Immunol; 2009 Jul; 39(7):1743-53. PubMed ID: 19551899 [TBL] [Abstract][Full Text] [Related]
20. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice. Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]